Key Points
-
Acute kidney injury (AKI) is not a single disease but a loose collection of syndromes characterized by an abrupt decrease in glomerular filtration rate
-
Broad classifications of AKI — according to the dominant aetiology (such as sepsis or nephrotoxicity) as opposed to pseudo-anatomical categories (for example, prerenal or intrarenal) — demonstrate more consistent relationships with pathophysiology and can improve therapeutic approaches
-
Broad aetiology-based classification may still be insufficient, as heterogeneity could exist at the molecular level; however, whether this heterogeneity leads to differences in response to therapy is not yet known
-
Protein biomarkers and other in vitro diagnostics are likely to have a role in both characterizing clinical phenotypes of AKI and aiding the discovery of new endophenotypes, with the ultimate goal of matching subsets of patients to effective therapeutic approaches
Abstract
Acute kidney injury (AKI) is a heterogeneous clinical syndrome that has multiple aetiologies, variable pathogenesis and diverse outcomes. However, these heterogeneities are not reflected in current approaches to the diagnosis and, to some degree, treatment of AKI. For example, congestive heart failure and dehydration can produce identical changes in serum creatinine level and urine output (parameters that are used to define AKI); however, they differ vastly in their physiological contexts and demand completely opposite treatments. AKI is often still considered to be a homogeneous clinical entity, which implies a uniform pathogenesis and a well-defined prognosis. As a consequence, efforts to find effective AKI treatments have been hampered by a lack of clear clinical classifications for various types of AKI. In addition, subclassification of AKI into subclinical phenotypes — for example, on the basis of protein biomarkers and other in vitro diagnostics that take into account disease aetiology and underlying pathogenesis — might be necessary to develop therapeutic approaches that effectively target the widely differing pathomechanisms of AKI. In this Review, we discuss the major subtypes of AKI that are associated with sepsis, major surgery, renal hypoperfusion and nephrotoxin exposure —situations that are typically seen in the intensive care setting. We consider differences and similarities in their phenotype, pathogenesis and outcomes and how this information might be used to guide treatment.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kellum, J. A., Bellomo, R. & Ronco, C. Kidney Attack. JAMA 307, 2265–2266 (2012).
Bedford, M., Stevens, P. E., Wheeler, T. W. K. & Farmer, C. K. T. What is the real impact of acute kidney injury? BMC Nephrol. 15, 95 (2014).
United States Renal Data System. 2013 Annual Data Report Vol. 1 Ch. 6 (USRDS, 2013).
Kane-Gill, S. L. et al. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am. J. Kidney Dis. 65, 860–869 (2015).
Murugan, R. et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int. 77, 527–535 (2010).
Sileanu, F. E. et al. AKI in low-risk versus high-risk patients in intensive care. Clin. J. Am. Soc. Nephrol. 10, 187–196 (2015).
Pickkers, P. et al. The intensive care medicine agenda on acute kidney injury. Intensive Care Med. 8, R204–R212 (2017).
Barasch, J., Zager, R. & Bonventre, J. V. Acute kidney injury: a problem of definition. Lancet 389, 779–781 (2017).
Uchino, S. et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294, 813–818 (2005).
Bagshaw, S. M. et al. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol. Dial. Transplant 23, 1203–1210 (2007).
Singbartl, K. & Kellum, J. A. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 81, 819–825 (2012).
Angus, D. C. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303–1310 (2001).
Bouchard, J. et al. A prospective international multicenter study of AKI in the intensive care unit. Clin. J. Am. Soc. Nephrol. 10, 1324–1331 (2015).
Vincent, J.-L. et al. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 34, 344–353 (2006).
Takasu, O. et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am. J. Respir. Crit. Care Med. 187, 509–517 (2013).
Langenberg, C., Gobe, G., Hood, S., May, C. N. & Bellomo, R. Renal histopathology during experimental septic acute kidney injury and recovery. Crit. Care Med. 42, e58–e67 (2014).
De Backer, D., Creteur, J., Preiser, J.-C., Dubois, M.-J. & Vincent, J.-L. Microvascular blood flow is altered in patients with sepsis. Am. J. Respir. Crit. Care Med. 166, 98–104 (2002).
Spronk, P. E. et al. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360, 1395–1396 (2002).
Donati, A. et al. The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome. BMC Anesthesiol. 13, 25 (2013).
Langenberg, C., Wan, L., Egi, M., May, C. N. & Bellomo, R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 69, 1996–2002 (2006).
Di Giantomasso, D., May, C. N. & Bellomo, R. Vital organ blood flow during hyperdynamic sepsis. Chest 124, 1053–1059 (2003).
Prowle, J. R. & Bellomo, R. Sepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulation. Semin. Nephrol. 35, 64–74 (2015).
Maiden, M. J. et al. Structure and function of the kidney in septic shock. a prospective controlled Exp. Study. Am. J. Respir. Crit. Care Med. 194, 692–700 (2016).
Benes, J. et al. Searching for mechanisms that matter in early septic acute kidney injury: an experimental study. Crit. Care 15, R256 (2011).
Gomez, H. et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock, 41, 3–11 (2014).
Verma, S. K. & Molitoris, B. A. Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin. Nephrol. 35, 96–107 (2015).
Post, E. H., Kellum, J. A., Bellomo, R. & Vincent, J.-L. Renal perfusion in sepsis: from macro- to microcirculation. Kidney Int. 91, 45–60 (2017).
Calzavacca, P., Evans, R. G., Bailey, M., Bellomo, R. & May, C. N. Cortical and medullary tissue perfusion and oxygenation in experimental septic acute kidney injury. Crit. Care Med. 43, e431–e439 (2015).
Lankadeva, Y. R. et al. Intrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury. Kidney Int. 90, 100–108 (2016).
Bezemer, R. et al. Real-time assessment of renal cortical microvascular perfusion heterogeneities using near-infrared laser speckle imaging. Opt. Express 18, 15054–15061 (2010).
Casellas, D. & Mimran, A. Aglomerular pathways in intrarenal microvasculature of aged rats. Am. J. Anat. 156, 293–299 (1979).
Dellepiane, S., Marengo, M. & Cantaluppi, V. Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapies. Crit. Care 20, 61 (2016).
Ghosh, C. C. et al. Gene control of tyrosine kinase TIE2 and vascular manifestations of infections. Proc. Natl Acad. Sci. USA 113, 2472–2477 (2016).
Mariano, F. et al. Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit. Care 12, R42 (2008).
Mehta, R. L. et al. Sepsis as a cause and consequence of acute kidney injury: program to improve care in acute renal disease. Intensive Care Med. 37, 241–248 (2010).
Singbartl, K. et al. Differential effects of kidney–lung cross-talk during acute kidney injury and bacterial pneumonia. Kidney Int. 80, 633–644 (2011).
Johnston, O., Zalunardo, N., Rose, C. & Gill, J. S. Prevention of sepsis during the transition to dialysis may improve the survival of transplant failure patients. J. Am. Soc. Nephrol. 18, 1331–1337 (2007).
Sarnak, M. J., Sarnak, M. J., Jaber, B. L. & Jaber, B. L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 58, 1758–1764 (2000).
Vanholder, R. & Ringoir, S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J. Am. Soc. Nephrol. 3, 1541–1554 (1993).
Winters, B. D. et al. Long-term mortality and quality of life in sepsis: a systematic review. Crit. Care Med. 38, 1276–1283 (2010).
Murugan, R. et al. Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol. Dial. Transplant 29, 1854–1864 (2014).
Kellum, J. A. et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am. J. Respir. Crit. Care Med. 193, 281–287 (2016).
Brunner, F. P., Thiel, G., Hermle, M., Bock, H. A. & Mihatsch, M. J. Long-term enalapril and verapamil in rats with reduced renal mass. Kidney Int. 36, 969–977 (1989).
Ikoma, M., Kawamura, T., Kakinuma, Y., Fogo, A. & Ichikawa, I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int. 40, 195–202 (1991).
Cheng, S.-Y. et al. Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury. Sci. Rep. 6, 34265 (2016).
Carmichael, P. & Carmichael, A. R. Acute renal failure in the surgical setting. ANZ J. Surg. 73, 144–153 (2003).
Shusterman, N. et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am. J. Med. 83, 65–71 (1987).
Weiser, T. G. et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet 385 (Suppl. 2), S11 (2015).
Weiser, T. G. et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372, 139–144 (2008).
Kork, F. et al. Minor postoperative increases of creatinine are associated with higher mortality and longer hospital length of stay in surgical patients. Anesthesiology 123, 1301–1311 (2015).
Korenkevych, D. et al. The pattern of longitudinal change in serum creatinine and 90-day mortality after major surgery. Ann. Surg. 263, 1219–1227 (2016).
Grams, M. E. et al. Acute kidney injury after major surgery: a retrospective analysis of veterans health administration data. Am. J. Kidney Dis. 67, 872–880 (2016).
Grams, M. E. et al. Candidate surrogate end points for ESRD after AKI. J. Am. Soc. Nephrol. 27, 2851–2859 (2016).
O'Connor, M. E. et al. Acute kidney injury and mortality 1 year after major non-cardiac surgery. Br. J. Surg. 104, 868–876 (2017).
O'Connor, M. E., Kirwan, C. J., Pearse, R. M. & Prowle, J. R. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med. 42, 521–530 (2016).
Thiele, R. H., Isbell, J. M. & Rosner, M. H. AKI associated with cardiac surgery. Clin. J. Am. Soc. Nephrol. 10, 500–514 (2015).
Chertow, G. M. et al. Preoperative renal risk stratification. Circulation 95, 878–884 (1997).
Prowle, J. R. et al. Preoperative renal dysfunction and mortality after non-cardiac surgery. Br. J. Surg. 103, 1316–1325 (2016).
Kheterpal, S. et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 110, 505–515 (2009).
Brienza, N., Giglio, M. T., Marucci, M. & Fiore, T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit. Care Med. 37, 2079–2090 (2009).
Prowle, J. R., Chua, H.-R., Bagshaw, S. M. & Bellomo, R. Clinical review: volume of fluid resuscitation and the incidence of acute kidney injury — a systematic review. Crit. Care 16, 230 (2012).
Sun, L. Y., Wijeysundera, D. N., Tait, G. A. & Beattie, W. S. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 123, 515–523 (2015).
Walsh, M. et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 119, 507–515 (2013).
Salmasi, V. et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 126, 47–65 (2017).
Saotome, T., Ishikawa, K., May, C. N., Birchall, I. E. & Bellomo, R. The impact of experimental hypoperfusion on subsequent kidney function. Intensive Care Med. 36, 533–540 (2010).
Siegemund, M. et al. Aortic cross-clamping and reperfusion in pigs reduces microvascular oxygenation by altered systemic and regional blood flow distribution. Anesth. Analg. 111, 345–353 (2010).
Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499–511 (2004).
Cremer, J. et al. Systemic inflammatory response syndrome after cardiac operations. Ann. Thorac. Surg. 61, 1714–1720 (1996).
Rosner, M. H., Portilla, D. & Okusa, M. D. Cardiac surgery as a cause of acute kidney injury: pathogenesis and potential therapies. J. Intensive Care Med. 23, 3–18 (2008).
Zhang, W. R. et al. Plasma IL-6 and IL-10 concentrations predict AKI and long-term mortality in adults after cardiac surgery. J. Am. Soc. Nephrol. 26, 3123–3132 (2015).
Andres-Hernando, A. et al. Cytokine production increases and cytokine clearance decreases in mice with bilateral nephrectomy. Nephrol. Dial. Transplant 27, 4339–4347 (2012).
Lahiri, R. et al. Systemic inflammatory response syndrome after major abdominal surgery predicted by early upregulation of TLR4 and TLR5. Ann. Surg. 263, 1028–1037 (2016).
Hobson, C. E. et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 119, 2444–2453 (2009).
Bihorac, A. et al. National surgical quality improvement program underestimates the risk associated with mild and moderate postoperative acute kidney injury. Crit. Care Med. 41, 2570–2583 (2013).
van Kuijk, J.-P. et al. Temporary perioperative decline of renal function is an independent predictor for chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 1198–1204 (2010).
Bihorac, A. et al. Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients. Ann. Surg. 252, 158–165 (2010).
Bihorac, A. et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann. Surg. 249, 851–858 (2009).
Ishani, A. et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch. Intern. Med. 171, 226–233 (2011).
Leacche, M. et al. Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am. J. Cardiol. 93, 353–356 (2004).
Thakar, C. V. et al. Predicting acute renal failure after cardiac surgery: validation and re-definition of a risk-stratification algorithm. Hemodial. Int. 7, 143–147 (2003).
Oliver, J., MacDowell, M. & Tracy, A. The pathogenesis of acute renal failure associated with traumatic and toxic injury; renal ischemia, nephrotoxic damage and the ischemic episode. J. Clin. Invest. 30, 1307–1439 (1951).
Sandroni, C. et al. Acute kidney injury after cardiac arrest: a systematic review and meta-analysis of clinical studies. Minerva Anestesiol. 82, 989–999 (2016).
Bonventre, J. V. & Yang, L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121, 4210–4221 (2011).
Sharfuddin, A. A. & Molitoris, B. A. Pathophysiology of ischemic acute kidney injury. Nat. Rev. Nephrol. 7, 189–200 (2011).
Prowle, J. R., Ishikawa, K., May, C. N. & Bellomo, R. Renal blood flow during acute renal failure in man. Blood Purif. 28, 216–225 (2009).
Mullens, W. et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J. Am. Coll. Cardiol. 53, 589–596 (2009).
Damman, K. et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J. Am. Coll. Cardiol. 53, 582–588 (2009).
Dalfino, L., Tullo, L., Donadio, I., Malcangi, V. & Brienza, N. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med. 34, 707–713 (2008).
O'Connor, M. E. & Prowle, J. R. Fluid Overload. Crit. Care Clin. 31, 803–821 (2015).
Lauridsen, M. D. et al. Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study. Crit. Care 19, 452 (2015).
Taber, S. S. & Mueller, B. A. Drug-associated renal dysfunction. Crit. Care Clin. 22, 357–374 (2006).
Hou, S. H., Bushinsky, D. A., Wish, J. B., Cohen, J. J. & Harrington, J. T. Hospital-acquired renal insufficiency: a prospective study. Am. J. Med. 74, 243–248 (1983).
Hui-Stickle, S., Brewer, E. D. & Goldstein, S. L. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am. J. Kidney Dis. 45, 96–101 (2005).
Liaño, F., Junco, E., Pascual, J., Madero, R. & Verde, E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Fail. Study Group. Kidney Int. Suppl. 66, S16–S24 (1998).
Nash, K., Hafeez, A. & Hou, S. Hospital-acquired renal insufficiency. Am. J. Kidney Dis. 39, 930–936 (2002).
Schetz, M., Dasta, J., Goldstein, S. & Golper, T. Drug-induced acute kidney injury. Curr. Opin. Crit. Care 11, 555–565 (2005).
Rosner, M. H. & Perazella, M. A. Acute Kidney Injury in Patients with Cancer. N. Engl. J. Med. 376, 1770–1781 (2017).
de Broe, M. E. & Porter, G. A. Clinical Nephrotoxins (eds DeBroe, M. E., Porter, G. A., Bennett, W. M. & Deray, G.) (Springer, 2008).
Ozkok, A. & Edelstein, C. L. Pathophysiology of cisplatin-induced acute kidney injury. Biomed. Res. Int. 2014, 967826 (2014).
Faubel, S. et al. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 322, 8–15 (2007).
Ramesh, G. & Reeves, W. B. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110, 835–842 (2002).
Sánchez-González, P. D., López-Hernández, F. J., López-Novoa, J. M. & Morales, A. I. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Crit. Rev. Toxicol. 41, 803–821 (2011).
Skinner, R. et al. Cisplatin dose rate as a risk factor for nephrotoxicity in children. Br. J. Cancer 77, 1677–1682 (1998).
Menon, S., Kirkendall, E. S., Nguyen, H. & Goldstein, S. L. Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J. Pediatr. 165, 522–527 (2014).
Kellum, J. A., Sileanu, F. E., Bihorac, A., Hoste, E. A. J. & Chawla, L. S. Recovery after acute kidney injury. Am. J. Respir. Crit. Care Med. 195, 784–791 (2017).
Molitoris, B. A. et al. Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis selected hospital settings. Clin. J. Am. Soc. Nephrol. 7, 856–860 (2012).
Chawla, L. S., Eggers, P. W., Star, R. A. & Kimmel, P. L. Acute kidney injury and chronic kidney disease as interconnected syndromes. N. Engl. J. Med. 371, 58–66 (2014).
Yuen, P. S. T., Jo, S.-K., Holly, M. K., Hu, X. & Star, R. A. Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. Physiol. Genom. 25, 375–386 (2006).
Mar, D. et al. Heterogeneity of epigenetic changes at ischemia/reperfusion- and endotoxin-induced acute kidney injury genes. Kidney Int. 88, 734–744 (2015).
Matejovic, M. et al. Molecular differences in susceptibility of the kidney to sepsis-induced kidney injury. BMC Nephrol. 18, 183 (2017).
Fan, P.-C., Chen, C.-C., Chen, Y.-C., Chang, Y.-S. & Chu, P.-H. MicroRNAs in acute kidney injury. Hum. Genom. 10, 29 (2016).
Xu, K. et al. Unique transcriptional programs identify subtypes of AKI. J. Am. Soc. Nephrol. 28, 1729–1740 (2017).
Paragas, N. et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat. Med. 17, 216–222 (2011).
Nickolas, T. L. et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J. Am. Coll. Cardiol. 59, 246–255 (2012).
Haase, M., Kellum, J. A. & Ronco, C. Subclinical AKI — an emerging syndrome with important consequences. Nat. Rev. Nephrol. 8, 735–739 (2012).
Borregaard, N. & Cowland, J. B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89, 3503–3521 (1997).
Kashani, K. et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit. Care 17, R25 (2013).
Bihorac, A. et al. Validation of cell-cycle arrest biomarkers for acute. Am. J. Respir. Crit. Care Med. 189, 932–939 (2014).
Honore, P. M. et al. Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis. Crit. Care Med. 44, 1851–1860 (2016).
Murugan, R. & Kellum, J. A. Acute kidney injury: what's the prognosis? Nat. Rev. Nephrol. 7, 209–217 (2011).
Koyner, J. L. et al. Tissue inhibitor metalloproteinase-2 (TIMP-2)ċIGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J. Am. Soc. Nephrol. 26, 1747–1754 (2015).
Bellomo, R. et al. Acute renal failure — definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8, R204–R212 (2004).
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1–138 (2012).
Kellum, J. A. et al. Classifying AKI by urine output versus serum creatinine level. J. Am. Soc. Nephrol. 26, 2231–2238 (2015).
Kaddourah, A., Basu, R. K., Bagshaw, S. M., Goldstein, S. L. & AWARE Investigators. Epidemiology of acute kidney injury in critically ill children and young adults. N. Engl. J. Med. 376, 11–20 (2017).
Author information
Authors and Affiliations
Contributions
J.A.K. and J.R.P. researched the data, discussed the article's content, wrote the text and reviewed or edited the article before submission.
Corresponding author
Ethics declarations
Competing interests
J.A.K. has received consulting fees and grant support from Astute Medical and Bioporto. J.R.P. declares no competing interests.
Glossary
- Inflammatory mediators
-
A wide array of substances that mediate and modulate various aspects of inflammation. These substances include vasoactive proteins (for example, bradykinin, histamine), complement and molecules involved in coagulation (for example, plasmin, thrombin). Cytokines (for example, TNF, IL-6, IL-10), chemokines (for example, IL-8) and eicosanoids (for example, leukotrienes, prostaglandins) are the major mediators of inflammation during infection. Although some molecules are often labelled pro-inflammatory (for example, IL-6) and others anti-inflammatory (for example, IL-10), the actions of each mediator may be complex and context-dependent, making simple classification difficult.
- Damage-associated molecular patterns
-
(DAMPs; also known as danger-associated molecular patterns). Endogenous molecules often released from damaged tissues or dying cells. They can be detected by various receptors on cells, including TLRs and receptor for advanced glycosylation end products (RAGE; also known as AGER). Typical DAMPs include high mobility group protein B1 (HMGB1), RNA, DNA and myoglobin.
- Pathogen-associated molecular patterns
-
(PAMPs). Similar to DAMPs, PAMPs are molecules released from pathogens. Many of the same receptors that recognize DAMPs also recognize PAMPs, leading to similar cellular responses when either are encountered. Typical PAMPs include lipopolysaccharide (LPS; also known as endotoxin), lipoteichoic acid from Gram-positive bacteria, peptidoglycan and nucleic acid variants normally associated with viruses.
Rights and permissions
About this article
Cite this article
Kellum, J., Prowle, J. Paradigms of acute kidney injury in the intensive care setting. Nat Rev Nephrol 14, 217–230 (2018). https://doi.org/10.1038/nrneph.2017.184
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2017.184
This article is cited by
-
Different distances between central venous catheter tips can affect antibiotic clearance during continuous renal replacement therapy
Intensive Care Medicine Experimental (2024)
-
A dynamic model to predict early occurrence of acute kidney injury in ICU hospitalized cirrhotic patients: a MIMIC database analysis
BMC Gastroenterology (2024)
-
Ultrasonographic assessment of renal microcirculation is a new vision for the treatment of intensive care unit associated acute kidney injury
European Journal of Medical Research (2024)
-
Künstliche Intelligenz und akute Nierenschädigung
Medizinische Klinik - Intensivmedizin und Notfallmedizin (2024)
-
MRI of kidney size matters
Magnetic Resonance Materials in Physics, Biology and Medicine (2024)